Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
acute toxicity: oral
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2018
Report date:
2018

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
GLP compliance:
yes (incl. QA statement)
Test type:
acute toxic class method

Test material

Constituent 1
Chemical structure
Reference substance name:
Benzyl 2-methoxy-4-prop-1-enylphenyl ether
EC Number:
204-370-6
EC Name:
Benzyl 2-methoxy-4-prop-1-enylphenyl ether
Cas Number:
120-11-6
Molecular formula:
C17H18O2
IUPAC Name:
benzyl 2-methoxy-4-prop-1-enylphenyl ether

Test animals

Species:
rat
Strain:
Sprague-Dawley
Sex:
female

Administration / exposure

Route of administration:
oral: unspecified
No. of animals per sex per dose:
3

Results and discussion

Effect levelsopen allclose all
Key result
Sex:
female
Dose descriptor:
LD50
Effect level:
> 2 000 mg/kg bw
Key result
Sex:
female
Dose descriptor:
LD50
Effect level:
5 000 mg/kg bw

Applicant's summary and conclusion

Interpretation of results:
GHS criteria not met
Conclusions:
The test item BENZYL ISO EUGENOL does not have to be classified in accordance with the Regulation EC no. 1272/2008 on classification, labelling and packaging of substances and mixtures. No signal word or hazard statement is required.
Executive summary:

The test item BENZYL ISO EUGENOL was administered to a group of 6 female Sprague Dawley rats at the dose of 2000 mg/kg bw. The experimental protocol was established according to the official method as defined in the OECD Test Guideline No. 423 dated December 17th, 2001 and the test method B.1tris of the Council regulation No. 440/2008 of 30 May 2008.

No mortality occured during the study.

No clinicals signs related to the administration of the test item were observed during the study.

The body weight evolution of the animals remained normal during the study.

The macroscopic examination of the animals at the end of the study did not reveal treatment related changes.

In conclusion, the LD50 of the test item BENZYL ISO EUGENOL is higher than 2000 mg/kg bw.

In accordance with the OECD Test Guideline No. 423, the LD50 cut-off of the test item may be considered as 5000 mg/kg bw by oral route in the rat.

The test item BENZYL ISO EUGENOL does not have to be classified in accordance with the Regulation EC No. 1272/2008 on classification, labelling and packaging of substances and mixtures.

No signal word or hazard statement is required.